William Earl Collins

William Earl Collins's AcademicInfluence.com Rankings

Biology

#8226

World Rank

#11269

Historical Rank

Genetics

#819

World Rank

#911

Historical Rank

biology Degrees

Download Badge

Biology

Why Is William Earl Collins Influential?

(Suggest an Edit or Addition)

(See a Problem?)

William Earl Collins's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Genetic selection of a Plasmodium-refractory strain of the malaria vector Anopheles gambiae. (1986) (492)
The evolution of primate malaria parasites based on the gene encoding cytochrome b from the linear mitochondrial genome. (1998) (351)
Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. (1986) (328)
Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax (1982) (271)
Plasmodium malariae: Parasite and Disease (2007) (258)
Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes (1999) (251)
Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. (1982) (220)
A monkey's tale: the origin of Plasmodium vivax as a human malaria parasite. (2005) (218)
Plasmodium ovale: Parasite and Disease (2005) (212)
Protective immunity induced in squirrel monkeys with recombinant apical membrane antigen-1 of Plasmodium fragile. (1994) (188)
Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. (2001) (186)
Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. (2001) (184)
Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum (1986) (168)
Antibodies to Malaria Vaccine Candidates Pvs25 and Pvs28 Completely Block the Ability of Plasmodium vivax To Infect Mosquitoes (2000) (162)
Primaquine resistance in Plasmodium vivax. (1996) (153)
A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity during primary infection. (1999) (148)
Plasmodium falciparum parasitaemia described by a new mathematical model (2001) (143)
Diagnosing infection levels of four human malaria parasite species by a polymerase chain reaction/ligase detection reaction fluorescent microsphere-based assay. (2006) (130)
Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection (2002) (129)
Experimental mosquito-transmission of Plasmodium knowlesi to man and monkey. (1968) (126)
Identification of Plasmodium vivax sporozoites in mosquitoes using an enzyme-linked immunosorbent assay. (1985) (122)
A retrospective examination of anemia during infection of humans with Plasmodium vivax. (2003) (117)
Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax. (2008) (117)
Plasmodium knowlesi: a malaria parasite of monkeys and humans. (2012) (112)
Geographic subdivision of the range of the malaria parasite Plasmodium vivax. (2001) (108)
A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. (1999) (107)
Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of the malaria parasite Plasmodium falciparum. (1993) (105)
A retrospective examination of sporozoite- and trophozoite-induced infections with Plasmodium falciparum in patients previously infected with heterologous species of Plasmodium: effect on development of parasitologic and clinical immunity. (1999) (103)
Immunogenicity and in vitro protective efficacy of a recombinant multistage Plasmodium falciparum candidate vaccine. (1999) (101)
The Clinical-Grade 42-Kilodalton Fragment of Merozoite Surface Protein 1 of Plasmodium falciparum Strain FVO Expressed in Escherichia coli Protects Aotus nancymai against Challenge with Homologous Erythrocytic-Stage Parasites (2005) (100)
Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax. (1992) (98)
Phylogenetic relationship among the malaria parasites based on small subunit rRNA gene sequences: monophyletic nature of the human malaria parasite, Plasmodium falciparum. (1996) (96)
A Systems-Based Analysis of Plasmodium vivax Lifecycle Transcription from Human to Mosquito (2010) (94)
Identification of Plasmodium vivax-like human malaria parasite (1993) (93)
Malaria sporozoite penetration. A new approach by double staining. (1988) (92)
Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. (1991) (89)
Anti-mosquito midgut antibodies block development of Plasmodium falciparum and Plasmodium vivax in multiple species of Anopheles mosquitoes and reduce vector fecundity and survivorship (2001) (88)
Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets. (2013) (88)
Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line (2002) (87)
High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model (2009) (86)
No place to unload: a preliminary analysis of the prevalence, risk factors, and consequences of ambulance diversion. (1994) (86)
PLASMODIUM VIVAX BLOOD-STAGE DYNAMICS (2002) (85)
Protection Induced by Plasmodium falciparum MSP142 Is Strain-Specific, Antigen and Adjuvant Dependent, and Correlates with Antibody Responses (2008) (84)
A retrospective examination of the patterns of recrudescence in patients infected with Plasmodium falciparum. (1999) (79)
In vitro culture of two populations (dividing and nondividing) of exoerythrocytic parasites of Plasmodium vivax. (1985) (79)
A primate model for human cerebral malaria: Plasmodium coatneyi-infected rhesus monkeys. (1992) (77)
Modelling the transition of asexual blood stages of Plasmodium falciparum to gametocytes. (2000) (73)
Studies on the characterization of plasmodium vivax strains from Central America. (1972) (68)
Malaria therapy reinoculation data suggest individual variation of an innate immune response and independent acquisition of antiparasitic and antitoxic immunities. (2002) (66)
Establishment of an In Vitro Assay for Assessing the Effects of Drugs on the Liver Stages of Plasmodium vivax Malaria (2010) (63)
Plasmodium vivax: in vitro growth and reinvasion in red blood cells of Aotus nancymai. (1988) (61)
Relative importance of risk factors in bladder carcinogenesis. (1978) (61)
Observations on early and late post-sporozoite tissue stages in primate malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North Korean strains of Plasmodium vivax in the chimpanzee. (1986) (58)
Diagnosis of malaria by magnetic deposition microscopy. (2006) (58)
Evaluation of clindamycin in combination with quinine against multidrug-resistant strains of Plasmodium falciparum. (1974) (56)
A retrospective examination of reinfection of humans with Plasmodium vivax. (2004) (56)
Species-specific 18S rRNA gene amplification for the detection of P. falciparum and P. vivax malaria parasites. (1995) (55)
Seroepidemiological studies of malaria in pregnant women and newborns from coastal El Salvador. (1980) (55)
Partial Protection against Plasmodium vivaxBlood-Stage Infection in Saimiri Monkeys by Immunization with a Recombinant C-Terminal Fragment of Merozoite Surface Protein 1 in Block Copolymer Adjuvant (1999) (53)
GAMETOCYTEMIA AND FEVER IN HUMAN MALARIA INFECTIONS (2007) (53)
The indirect fluorescent antibody test for malaria. (1972) (52)
Nonhuman Primate Models (2002) (52)
A retrospective examination of mosquito infection on humans infected with Plasmodium falciparum. (2003) (51)
A nonhuman primate model for human cerebral malaria: rhesus monkeys experimentally infected with Plasmodium fragile. (1994) (50)
Evidence of purifying selection on merozoite surface protein 8 (MSP8) and 10 (MSP10) in Plasmodium spp. (2012) (50)
Immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax. (1989) (50)
Apical membrane antigen of Plasmodium fragile. (1990) (50)
Studies on the transmission of simian malarias, I. Transmission of two strains of Plasmodium inui by Anopheles maculatus and A. stephensi. (1966) (49)
Testing the efficacy of a recombinant merozoite surface protein (MSP-1(19) of Plasmodium vivax in Saimiri boliviensis monkeys. (1999) (49)
Inhibition of malaria parasite development in mosquitoes by anti-mosquito-midgut antibodies (1994) (49)
Relationship of serum complement levels to events of the malarial paroxysm. (1974) (48)
A comparative study of the genetic diversity of the 42kDa fragment of the merozoite surface protein 1 in Plasmodium falciparum and P. vivax. (2007) (47)
Community-based malaria control in Saradidi, Kenya: description of the programme and impact on parasitaemia rates and antimalarial antibodies. (1987) (46)
Transmission of Plasmodium schwetzi from the chimpanzee to man by mosquito bite. (1970) (45)
Immunization of monkeys against Plasmodium cynomolgi by X-irradiated sporozoites. (1972) (45)
Transmission of four Central American strains of Plasmodium vivax from monkey to man. (1972) (44)
Simian malaria in a U.S. traveler--New York, 2008. (2009) (44)
Concentration of Plasmodium ovale- and Plasmodium vivax-infected erythrocytes from nonhuman primate blood using Percoll gradients. (1986) (44)
A study of polymorphism in the circumsporozoite protein of human malaria parasites. (1994) (44)
Circumsporozoite protein gene from Plasmodium brasilianum. Animal reservoirs for human malaria parasites? (1988) (44)
Plasmodium malariae infection boosts Plasmodium falciparum gametocyte production. (2002) (44)
Efficacy of vaccines containing rhoptry-associated proteins RAP1 and RAP2 of Plasmodium falciparum in Saimiri boliviensis monkeys. (2000) (43)
Widespread reactivity of human sera with a variant repeat of the circumsporozoite protein of Plasmodium vivax. (1990) (42)
Studies on the Santa Lucia (El Salvador) strain of Plasmodium falciparum in Aotus trivirgatus monkeys. (1977) (41)
The Duffy blood group and resistance to Plasmodium vivax in Honduras. (1978) (41)
The Chesson strain of Plasmodium vivax in Aotus monkeys and anopheline mosquitoes. (1980) (41)
Studies on the transmission of simian malarias. II. Transmission of the H strain of Plasmodium knowlesi by Anopheles balabacensis balabacensis. (1967) (41)
Major animal models in malaria research: simian. (1988) (40)
Immunization of owl monkeys with a combination of Plasmodium falciparum asexual blood-stage synthetic peptide antigens. (1990) (39)
Parasite prevalence: a static measure of dynamic infections. (2007) (39)
Plasmodium malariae Blood-Stage Dynamics (2001) (39)
Studies on a primaquine-tolerant strain of Plasmodium vivax from Brazil in Aotus and Saimiri monkeys. (1997) (39)
Structure of the circumsporozoite gene of Plasmodium malariae. (1988) (39)
Potent immunogenicity of DNA vaccines encoding Plasmodium vivax transmission-blocking vaccine candidates Pvs25 and Pvs28-evaluation of homologous and heterologous antigen-delivery prime-boost strategy. (2004) (39)
Evaluation of monoclonal antibodies against Plasmodium vivax sporozoites for ELISA development (1991) (38)
Selection of different strains of Plasmodium falciparum for testing blood-stage vaccines in Aotus nancymai monkeys. (1994) (38)
Two new karyotypes in the Peruvian owl monkey (Aotus trivirgatus) (1985) (38)
In vitro culture of exoerythrocytic parasites of the North Korean strain of Plasmodium vivax in hepatoma cells. (1986) (37)
Studies on the persistence of malarial antibody response. (1968) (37)
Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin. (1997) (37)
The enzyme-linked immunosorbent assay (ELISA) for malaria. I. The use of in vitro-cultured Plasmodium falciparum as antigen. (1979) (37)
A retrospective examination of sporozoite-induced and trophozoite-induced infections with Plasmodium ovale: development of parasitologic and clinical immunity during primary infection. (2002) (36)
Infectivity of the Santa Lucia (El Salvador) strain of Plasmodium falciparum to different anophelines. (1977) (36)
Monoclonal antibodies produced against sporozoites of the human parasite Plasmodium malariae abolish infectivity of sporozoites of the simian parasite Plasmodium brasilianum (1985) (36)
Fluorescent antibody studies in human malaria. IV. Cross-reactions between human and simian malaria. (1966) (36)
Sporozoite-induced infections of the Salvador I strain of Plasmodium vivax in Saimiri sciureus boliviensis monkeys. (1988) (35)
Assessment of transmission-blocking activity of candidate Pvs25 vaccine using gametocytes from chimpanzees. (2006) (35)
Localization of circumsporozoite protein of Plasmodium ovale in midgut oocysts (1987) (35)
Plasmodium falciparum gametocytes from culture in vitro develop to sporozoites that are infectious to primates. (1982) (35)
Plasmodium knowlesi: finally being recognized. (2009) (35)
A Preliminary Comparison of the Thrombogenic Activity of Vitronectin and Other RGD‐containing Proteins When Bound to Surfaces a (1987) (35)
Studies on human malaria in Aotus monkeys. I. Sporozoite transmission of Plasmodium vivax from El Salvador. (1973) (35)
Virus infection stages and distinct Th1 or Th17/Th22 T-cell responses in malaria/SHIV coinfection correlate with different outcomes of disease. (2011) (34)
Plasmodium malariae: distribution of circumsporozoite protein in midgut oocysts and salivary gland sporozoites. (1988) (34)
Cultivation in vitro of the vivax-type malaria parasite Plasmodium cynomolgi. (1981) (33)
Phylogenetic study of the genus Plasmodium based on the secondary structure-based alignment of the small subunit ribosomal RNA. (1997) (33)
Plasmodium ovale: in vitro development of hepatic stages. (1987) (32)
Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum. (1991) (32)
Polymerase chain reaction and a liquid-phase, nonisotopic hybridization for species-specific and sensitive detection of malaria infection. (1995) (32)
Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans). (1988) (31)
Expression of proinflammatory cytokines in four regions of the brain in Macaque mulatta (rhesus) monkeys infected with Plasmodium coatneyi. (2000) (31)
South American monkeys in the development and testing of malarial vaccines--a review. (1992) (31)
In vitro activity of antimalarial compounds on the exoerythrocytic stages of Plasmodium cynomolgi and P. knowlesi. (1989) (31)
Studies of the Sal I strain of Plasmodium vivax in the squirrel monkey (Saimiri sciureus). (1983) (31)
Evaluation of sporontocidal compounds using Plasmodium falciparum gametocytes produced in vitro. (1985) (31)
Evaluation of the micro enzyme-linked immunosorbent assay for antibodies to Trypanosoma cruzi. (1980) (30)
Monoclonal antibody identifies circumsporozoite protein of Plasmodium malariae and detects a common epitope on Plasmodium brasilianum sporozoites (1984) (30)
8 – The Owl Monkey as a Model for Malaria (1994) (30)
Serum complement and immunity in experimental simian malaria. I. Cyclical alterations in C4 related to schizont rupture. (1975) (30)
Plasmodium coatneyi: observations on periodicity, mosquito infection, and transmission to Macaca mulatta monkeys. (2001) (29)
Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism. (2001) (29)
Protective immunity induced in squirrel monkeys with a multiple antigen construct against the circumsporozoite protein of Plasmodium vivax. (1997) (29)
Blood and sporozoite stage-specific small subunit ribosomal RNA-encoding genes of the human malaria parasite Plasmodium vivax. (1994) (28)
EXPERIMENTAL INFECTION OF ANOPHELES FARAUTI WITH DIFFERENT SPECIES OF PLASMODIUM (2002) (28)
Studies on the North Korean strain of Plasmodium vivax in Aotus monkeys and different anophelines. (1985) (28)
FLUORESCENT ANTIBODY STUDIES IN HUMAN MALARIA. II. DEVELOPMENT AND PERSISTENCE OF ANTIBODIES TO PLASMODIUM FALCIPARUM. (1964) (28)
Protective Efficacy of a Plasmodium vivax Circumsporozoite Protein-Based Vaccine in Aotus nancymaae Is Associated with Antibodies to the Repeat Region (2014) (27)
A retrospective examination of the effect of fever and microgametocyte count on mosquito infection on humans infected with Plasmodium vivax. (2004) (27)
Observations on the infectivity of two strains of Plasmodium vivax from Vietnamese refugees to Aotus monkeys and anopheline mosquitoes. (1983) (27)
Immunogenicity in rhesus of the Plasmodium vivax mosquito stage antigen Pvs25H with Alhydrogel and Montanide ISA 720 (2007) (27)
Circumsporozoite protein gene of Plasmodium simium, a Plasmodium vivax-like monkey malaria parasite. (1993) (26)
Infection of Aotus azarae boliviensis monkeys with different strains of Plasmodium falciparum. (1985) (26)
Detection of Plasmodium falciparum, P. vivax, P. ovale, and P. malariae Merozoite Surface Protein 1-p19 Antibodies in Human Malaria Patients and Experimentally Infected Nonhuman Primates (2010) (26)
Comparison of genomic, plasmid, synthetic, and combined DNA probes for detecting Plasmodium falciparum DNA (1987) (26)
Studies on the relationship between fluorescent antibody response and ecology of malaria in Malaysia. (1968) (25)
The continuous cultivation of Plasmodium fragile by the method of Trager-Jensen. (1979) (25)
The sporogonic cycle of Plasmodium reichenowi. (1986) (25)
Effect of adjuvant formulations on the selection of B-cell epitopes expressed by a malaria peptide vaccine. (1992) (25)
Cytokine production in rhesus monkeys infected with Plasmodium coatneyi. (1999) (25)
Further studies on the sporozoite transmission of the Salvador I strain of Plasmodium vivax. (1994) (24)
Infection of the squirrel monkey Saimiri sciureus, with Plasmodium knowlesi. (1978) (24)
Susceptibility of Macaca fascicularis monkeys from Mauritius to different species of Plasmodium. (1992) (24)
Ultrastructure of the erythrocytic stages of Plasmodium malariae. (1987) (24)
Monoclonal antibody-based enzyme-linked immunosorbent assay (ELISA) for detection of Plasmodium malariae sporozoites in mosquitoes. (1988) (24)
Sequence variations in the non-repetitive regions of the liver stage-specific antigen-1 (LSA-1) of Plasmodium falciparum from field isolates. (1995) (24)
FLUORESCENT ANTIBODY STUDIES IN HUMAN MALARIA.I. DEVELOPMENT OF ANTIBODIES TO PLASMODIUM MALARIAE. (1964) (23)
Studies on human malaria in Aotus monkeys. IV. Development of Plasmodium falciparum in two subspecies of Aotus trivirgatus. (1974) (23)
Infection of mosquitoes with Plasmodium vivax from chimpanzees using membrane feeding. (1986) (23)
Effect of sequential infection with Plasmodium vivax and P. falciparum in the Aotus trivirgatus monkey. (1979) (23)
Fluorescent antibody studies in human malaria. V. Response of sera from Nigerians to five Plasmodium antigens. (1967) (23)
Evidence for negative selection on the gene encoding rhoptry-associated protein 1 (RAP-1) in Plasmodium spp. (2010) (23)
Adaptation of a chloroquine-resistant strain of Plasmodium vivax from Indonesia to New World monkeys. (2000) (22)
Studies on infections with the Berok strain of Plasmodium cynomolgi in monkeys and mosquitoes. (1999) (22)
Studies on the Salvador I strain of Plasmodium vivax in non-human primates and anopheline mosquitoes. (2009) (22)
Morphologic variants of Anopheles albimanus and susceptibility to Plasmodium vivax and P. falciparum. (1977) (22)
Immunogenicity of the Plasmodium falciparum asexual blood-stage synthetic peptide vaccine SPf66. (1993) (21)
Falciparum Malaria Transmissible from Monkey to Man by Mosquito Bite (1968) (21)
Infection of Peruvian Aotus nancymai monkeys with different strains of Plasmodium falciparum, P. vivax, and P. malariae. (1988) (21)
Five day primaquine therapy--an evaluation of radical curative activity against vivax malaria infection. (1973) (21)
Stage-specific and species-specific antigens of Plasmodium vivax and Plasmodium ovale defined by monoclonal antibodies (1986) (21)
Malaria chemoprophylaxis to pregnant women provided by community health workers in Saradidi, Kenya. III. Serologic studies. (1987) (21)
Infection of Aotus vociferans (karyotype V) monkeys with different strains of Plasmodium vivax. (1987) (21)
The susceptibility of the Indonesian I/CDC strain of Plasmodium vivax to chloroquine. (1992) (21)
Studies on the exoerythrocytic stages of simian malaria. VII. Plasmodium simiovale. (1967) (21)
Cultivation of exoerythrocytic stages of Plasmodium cynomolgi, P. knowlesi, P. coatneyi, and P. inui in Macaca mulatta hepatocytes. (1988) (21)
Localization of circumsporozoite antigen in exoerythrocytic schizonts of Plasmodium cynomolgi. (1989) (20)
FLUORESCENT ANTIBODY STUDIES IN HUMAN MALARIA. 3. DEVELOPMENT OF ANTIBODIES TO PLASMODIUM FALCIPARUM IN SEMI-IMMUNE PATIENTS. (1964) (20)
A correlation of the sequestration rate of Plasmodium coatneyi-infected erythrocytes in cerebral and subcutaneous tissues of a rhesus monkey. (1996) (20)
ANTIMALARIAL DRUG TRIALS ON A MULTIRESISTANT STRAIN OF PLASMODIUM FALCIPARUM. (1963) (20)
Cultivation in vitro of the quartan malaria parasite Plasmodium inui. (1980) (20)
In vitro cultivation of exoerythrocytic stages of the human malaria parasite Plasmodium malariae. (1988) (20)
Studies on human malaria in Aotus monkey. VII. Comparative infectivity of two strains of Plasmodium vivax to to Anopheles freeborni, A. maculatus, and for strains of A. albimanus. (1976) (20)
Failure to detect hypnozoites in hepatic tissue containing exoerythrocytic schizonts of Plasmodium knowlesi. (1982) (20)
A hopeful beginning for malaria vaccines. (2008) (20)
Studies on the Uganda I/CDC strain of Plasmodium malariae in bolivian Aotus monkeys and various anophelines. (1984) (20)
Further studies on the immunization of Saimiri sciureus boliviensis with recombinant vaccines based on the circumsporozoite protein of Plasmodium vivax. (1990) (19)
Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys (1996) (19)
Studies on human malaria in Aotus monkeys. V. Blood-induced infections of Plasmodium vivax. (1974) (19)
The Santa Lucia strain of Plasmodium falciparum as a model for vaccine studies. I. Development in Aotus lemurinus griseimembra monkeys. (1996) (19)
The seroepidemiology of malaria in Middle America. II. Studies on the Pacific coast of Costa Rica. (1975) (18)
Studies on human malaria in aotus monkeys. 3. Exoerythrocytic stages of the Salvador II strain of Plasmodium vivax. (1973) (18)
ADAPTATION OF A STRAIN OF PLASMODIUM VIVAX FROM INDIA TO NEW WORLD MONKEYS, CHIMPANZEES, AND ANOPHELINE MOSQUITOES (2001) (18)
Infecting dose and severity of falciparum malaria. (1995) (18)
Infectivity of two strains of Plasmodium vivax to Anopheles albitarsis mosquitoes from Colombia. (1985) (18)
Further understanding the nature of relapse of Plasmodium vivax infection. (2007) (18)
Plasmodium vivax: exoerythrocytic schizonts recognized by monoclonal antibodies against blood-stage schizonts. (1987) (18)
Comparative studies of three strains of Plasmodium falciparum isolated by the culture method of Trager and Jensen. (1980) (17)
Class II positive human dermal fibroblasts restimulate cloned allospecific T cells but fail to stimulate primary allogeneic lymphoproliferation. (1985) (17)
Chesson strain Plasmodium vivax in Saimiri sciureus boliviensis monkeys. (1987) (17)
Studies on the Indochina I/CDC strain of Plasmodium falciparum in Colombian and Bolivian Aotus monkeys and different anophelines. (1983) (17)
Use of non-human primate hepatocytes for in vitro study of the pre-erythrocytic stages of malaria parasites. (1990) (17)
Infection of Anopheles freeborni by gametocytes of cultured Plasmodium falciparum. (1980) (17)
Sporozoite transmission of three strains of Plasmodium knowlesi to Aotus and Saimiri monkeys. (1996) (17)
Hypnozoites of Plasmodium simiovale. (1991) (17)
Aotus nancymaae as a potential model for the testing of anti-sporozoite and liver stage vaccines against Plasmodium falciparum. (2006) (17)
Adaptation of a strain of Plasmodium vivax from Mauritania to New World monkeys and anopheline mosquitoes. (1998) (16)
Plasmodium inui is not closely related to other quartan Plasmodium species. (1998) (16)
The exoerythrocytic stages of Plasmodium falciparum in Aotus trivirgatus. (1969) (16)
The enzyme-linked immunosorbent assay (ELISA) for malaria. II. Comparison with the malaria indirect fluorescent antibody test (IFA). (1979) (16)
Plasmodium coatneyi-infected rhesus monkeys: a primate model for human cerebral malaria. (1992) (16)
Malarial relapse mechanism (1973) (16)
Sensitivity of four Central American strains of Plasmodium vivax to primaquine. (1974) (15)
Adaptation of a strain of Plasmodium falciparum from Ghana to Aotus lemurinus griseimembra, A. nancymai, and A. vociferans monkeys. (2003) (15)
Effect of thrombospondin and other platelet alpha-granule proteins on artificial surface-induced thrombosis. (1982) (15)
Adaptation of the AMRU-1 strain of Plasmodium vivax to Aotus and Saimiri monkeys and to four species of anopheline mosquitoes. (1999) (15)
Plasmodium vivax infections in chimpanzees for sporozoite challenge studies in monkeys. (1996) (15)
Assessment of a synthetic DNA probe for Plasmodium falciparum in African blood specimens. (1987) (15)
Serological malaria survey in the Ethiopian highlands. (1971) (15)
Infection of chimpanzees with Nigerian I/CDC strain of Plasmodium ovale. (1987) (15)
Studies on a newly isolated strain of Plasmodium brasilianum in Aotus and Saimiri monkeys and different anophelines. (1985) (15)
Application of the indirect fluorescent antibody method in a study of malaria endemicity in Mato Grosso, Brazil. (1975) (15)
Transmission of Plasmodium fragile to Saimiri monkeys. (1990) (15)
Susceptibility of Panamanian Aotus lemurinus lemurinus to sporozoite-induced Plasmodium falciparum (Santa Lucia) infection. (1999) (15)
Patterns of antibody and serum proteins in experimentally induced human malaria. (1971) (15)
Transmission of Plasmodium fragile to Aotus trivirgatus monkeys. (1974) (14)
Electron microscopy of Plasmodium vivax exoerythrocytic schizonts grown in vitro in a hepatoma cell line. (1985) (14)
Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines (2005) (14)
The seroepidemiology of malaria in Middle America. III. Serologic assessment of localized Plasmodium falciparum epidemics. (1976) (14)
Observations on the sporogonic cycle and transmission of Plasmodium simium Da Fonseca. (1969) (14)
Monkey to man transmission of Plasmodium falciparum by Anopheles freeborni mosquitoes. (1968) (14)
Observations on the relapse activity of Plasmodium fieldi in the rhesus monkey. (1971) (14)
Infection of Aotus azarae boliviensis monkeys with the RO strain of Plasmodium cynomolgi. (1985) (14)
The seroepidemiology of malaria in Middle America. I. Longitudinal studies on populations in a low incidence area of El Salvador. (1975) (14)
Susceptibility of Peruvian Aotus monkeys to infection with different species of Plasmodium. (1981) (14)
Influence of adjuvants on murine immune responses against the C‐terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein‐1 (MSP‐1) (1996) (14)
Reinforcement of immunity in Saimiri monkeys following immunization with irradiated sporozoites of Plasmodium vivax. (1992) (14)
The evolution and diversity of a low complexity vaccine candidate, merozoite surface protein 9 (MSP-9), in Plasmodium vivax and closely related species. (2013) (14)
Gametocytocidal and sporontocidal effects of antimalarial drugs on malaria parasites. II. Action of the folic reductase inhibitors, chlorguanide, and pyrimethamine against Plasmodium cynomolgi. (1974) (14)
Studies on the West African I strain of Plasmodium falciparum in Aotus trivirgatus monkeys. (1979) (13)
Adaptation of cultured Plasmodium falciparum to the intact squirrel monkey (Saimiri sciureus). (1980) (13)
Characterization of Plasmodium falciparum cloned lines with respect to gametocyte production in vitro, infectivity to Anopheles mosquitoes, and transmission to Aotus monkeys. (1987) (13)
The Santa Lucia strain of Plasmodium falciparum as a model for vaccine studies. II. Development of Aotus vociferans as a model for testing transmission-blocking vaccines. (1996) (13)
Nonhuman primate models. II. Infection of Saimiri and Aotus monkeys with Plasmodium vivax. (2002) (13)
Selection of increased quinine resistance in Plasmodium falciparum in Aotus monkeys. (1978) (13)
Evidence for an Increased Risk of Transmission of Simian Immunodeficiency Virus and Malaria in a Rhesus Macaque Coinfection Model (2011) (13)
Attempts to immunize monkeys against Plasmodium knowlesi by using heat-stable, serum-soluble antigens. (1977) (13)
Development of different strains of Plasmodium vivax in two species of Anopheles. (1976) (13)
Studies on the transmission of simian malaria. IV. Further studies on the transmission of Plasmodium knowlesi by Anopheles balabacensis balabacensis mosquitoes. (1971) (13)
Tick transmission of Babesia microti to rhesus monkeys (Macaca mulatta). (1981) (13)
Use of glass beads and CF 11 cellulose for removal of leukocytes from malaria-infected human blood in field settings. (1992) (13)
Persistence of malarial antibody. Findings in patients infected during the outbreak of malaria in Lake Vera, California, 1952-1953. (1967) (13)
Transmission of the OS strain of Plasmodium inui to Saimiri sciureus boliviensis and Aotus azarae boliviensis monkeys by Anopheles dirus mosquitoes. (1988) (12)
Observations on the biological nature of Plasmodium vivax sporozoites. (1996) (12)
Development of Plasmodium inui in the Aotus trivirgatus monkey. (1981) (12)
Specificity of the circum-sporozoite precipitation antigen(s) of human and simian malarias. (1976) (12)
Studies on human malaria in Aotus monkeys. II. Establishment of a strain of Plasmodium falciparum from Panama. (1973) (12)
Studies on the transmission of simian malaria. VI. Mosquito infection and sporozoite transmission of Plasmodium fragile. (1975) (12)
Experimental infection in man with Plasmodium malariae. (1973) (12)
Studies on the prophylactic and radical curative activity of RC-12 against Plasmodium cynomolgi in Macaca mulatta. (1972) (12)
Adaptation of the Indochina I/CDC strain of Plasmodium falciparum to the squirrel monkey (Saimiri sciureus). (1986) (12)
Studies on the West Pakistan strain of Plasmodium vivax in Aotus monkeys and anopheline mosquitoes. (1980) (12)
Infection of Aotus and Saimiri Monkeys with Plasmodium gonderi (2002) (12)
Comparative infectivity of a strain of Plasmodium falciparum from Panama to three species of Anopheles as studied by membrane feeding. (1964) (12)
Transmission of Plasmodium falciparum from monkey to monkey by the bite of infected Anopheles freeborni mosquitoes. (1972) (12)
Use of the rhesus monkey as an experimental model to test the degree of efficacy of an anti-sporozoite peptide malaria vaccine candidate combined with copolymer-based adjuvants. (1995) (12)
Transmission of Plasmodium cynomolgi to Aotus trivirgatus monkeys. (1975) (12)
Plasmodium fragile and Macaca mulatta monkeys as a model system for the study of malaria vaccines. (1979) (12)
Experimental inoculation of immunosuppressed owl monkeys with Pneumocystis carinii f. sp. hominis. (1999) (11)
Plasmodium simium in the Aotus trivirgatus monkey. (1973) (11)
Experimental Babesia microti infections in Macaca mulatta: recurrent parasitemia before and after splenectomy. (1981) (11)
Inhibitory activity against sporozoites induced by antibodies directed against nonrepetitive regions of the circumsporozoite protein of Plasmodium vivax (1992) (11)
Specific detection of Plasmodium falciparum malaria by a molecularly cloned DNA probe. (1986) (11)
Additional Observations on the Sporozoite Transmission of Plasmodium knowlesi to Monkeys (2004) (11)
Attempts to transmit the N-3 strain of Plasmodium fieldi to Aotus monkeys. (1998) (11)
The use of dimethyl sulfoxide in the low-temperature frozen preservation of experimental malarias. (1963) (11)
Plasmodium ovale: observations on the parasite development in Saimiri monkey hepatocytes in vivo and in vitro in contrast with its inability to induce parasitemia. (1994) (11)
Nonhuman primate models. I. Nonhuman primate host-parasite combinations. (2002) (11)
Strain specificity in the liver-stage development of Plasmodium falciparum in primary cultures of new world monkey hepatocytes. (1991) (11)
Antibodies to Pf155, a major antigen of Plasmodium falciparum: longitudinal studies in humans. (1987) (11)
A survey of malaria in Indochinese refugees arriving in the United States, 1980. (1982) (11)
Inhibitory activity against Plasmodium vivax sporozoites induced by plasma from Saimiri monkeys immunized with circumsporozoite recombinant proteins or irradiated sporozoites. (1991) (11)
Gametocytocidal and sporontocidal effects of antimalarial drugs on malaria parasites. I. Effect of single and multiple doses of primaquine on Plasmodium cynomolgi. (1973) (11)
Studies on the exoerythrocytic stages of simian malaria. VIII. (1973) (11)
ISOLATES OF PLASMODIUM INUI ADAPTED TO MACACA MULATTA MONKEYS AND LABORATORY-REARED ANOPHELINE MOSQUITOES FOR EXPERIMENTAL STUDY (2007) (10)
Transmission of Plasmodium simium to Aotus nancymai, A. vociferans, A. azarae boliviensis, and Saimiri sciureus boliviensis monkeys. (1987) (10)
Plasmodium inui: serologic relationships of Asian isolates. (1970) (10)
The Peruvian III strain of Plasmodium brasilianum in Saimiri sciureus boliviensis monkeys. (1990) (10)
The China I/CDC strain of Plasmodium malariae in Aotus monkeys and chimpanzees. (1994) (10)
The seroepidemiology of malaria in Middle America. V. Antibody responses in an indicator population from an endemic area with attack phase antimalaria activities. (1983) (10)
Some Observations on the Sporogonic Cycle of Plasmodium schwetzi, P. vivax and P. ovale in Five Species of Anopheles (1969) (10)
Salvador II strain of Plasmodium vivax in Aotus monkeys and mosquitoes for transmission-blocking vaccine trials. (1998) (10)
Plasmodium hylobati: a malaria parasite of the gibbon. (1972) (10)
Observations on two strains of plasmodium falciparum from Haiti in Aotus monkeys. (1982) (10)
The Chesson strain of plasmodium vivax in humans and different species of Aotus monkeys. (2009) (10)
In vitro and in vivo adaptation of the Geneve/SGE-1 strain of Plasmodium falciparum to growth in a squirrel monkey (Saimiri sciureus) model. (1987) (10)
Plasmodium simium and Saimiri boliviensis as a model system for testing candidate vaccines against Plasmodium vivax. (2005) (9)
Transmission of three strains of Plasmodium falciparum from monkey to man. (1973) (9)
Studies of comparative infectivity of fifteen strains of Plasmodium vivax to laboratory-reared anopheline mosquitoes, with special reference to Anopheles culicifacies. (1986) (9)
Infection of Aotus vociferans monkeys with different strains of Plasmodium falciparum. (1991) (9)
Impaired renal function in owl monkeys (Aotus nancymai) infected with Plasmodium falciparum. (1992) (9)
Studies on human malaria in Aotus monkeys. VI. Infectivity of Plasmodium malariae to different Anophelines. (1975) (9)
Infection of Saimiri boliviensis Monkeys With Plasmodium coatneyi (2005) (9)
Antibody responses to malarial antigens in the Wopkaimin population of the Star Mountains, Papua New Guinea. (1988) (9)
CHAPTER 3 – Plasmodia of Nonhuman Primates (1993) (9)
Studies on the antimalarial effects of RC-12 and WR 14,997 on the development of Plasmodium cynomolgi in mosquitoes and Rhesus monkeys. (1974) (9)
Ex vivo platelet deposition on fibronectin-preadsorbed surfaces. (1987) (9)
Antibody response to heterologous and homologous antigens in Brugia malayi- and B. pahangi-infected Mongolian jirds as measured by the enzyme-linked immunosorbent assay (ELISA). (1981) (9)
The enzyme-linked immunosorbent assay (ELISA) for malaria. III. Antibody response in documented Plasmodium falciparum infections. (1981) (9)
In vitro cultivation of exoerythrocytic stages of the simian malaria parasites Plasmodium fieldi and Plasmodium simiovale in rhesus monkey hepatocytes. (1994) (9)
Comparative infectivity of two strains of Plasmodium falciparum to Anopheles quadrimaculatus Say, Anopheles freeborni Aitken, and Anopheles albimanus (Wied.). (1963) (9)
Infectivity of Plasmodium malariae in the Aotus trivirgatus monkey to Anopheles freeborni mosquitoes. (1969) (9)
Susceptibility of Anopheles farauti to infection with different species of Plasmodium. (2004) (9)
Circumsporozoite protein of the human malaria parasite Plasmodium ovale identified with monoclonal antibodies (1988) (9)
Plasmodium malariae: Transmission from Monkey to Man by Mosquito Bite (1969) (9)
Infection of chimpanzees with the Uganda I/CDC strain of Plasmodium malariae. (1990) (9)
Combined chloroquine-primaquine therapy against vivax malaria. (1974) (8)
Role of insects in the transmission of bovine leukosis virus: potential for transmission by mosquitoes. (1982) (8)
Infection of Aotus azarae boliviensis monkeys with different strains of Plasmodium vivax. (1985) (8)
The Malayan IV strain of Plasmodium falciparum in Aotus monkeys. (1997) (8)
Adaptation of a strain of Plasmodium falciparum from a Montagnard refugee to Aotus monkeys. (1997) (8)
The Uganda I/CDC strain of Plasmodium malariae in Aotus lemurinus griseimembra monkeys. (1989) (8)
Anopheles pseudopunctipennis: laboratory maintenance and malaria susceptibility of a strain from El Salvador. (1980) (8)
STUDIES ON SPOROZOITE-INDUCED AND CHRONIC INFECTIONS WITH PLASMODIUM FRAGILE IN MACACA MULATTA AND NEW WORLD MONKEYS (2006) (8)
Studies on the Burma (Thau.) strain of Plasmodium falciparum in Aotus trivirgatus monkeys. (1978) (8)
Selected pupal phenotypes of Anopheles freeborni and their susceptibility to Plasmodium falciparum and P. vivax. (1979) (8)
The 48-hour exoerythrocytic stage of Plasmodium cynomolgi bastianellii. (1981) (8)
The Development of Exoerythrocytic Stages of Plasmodium inui shortti in New World Monkeys (2003) (8)
Plasmodium inui and Babesia microti infections in the squirrel monkey, Saimiri sciureus. (1983) (8)
Development of a polymorphic strain of Plasmodium vivax in monkeys. (1992) (8)
Detection of early exoerythrocytic schizonts of Plasmodium cynomolgi by immunofluorescence. (1973) (8)
Anopheles gambiae as a host for geographic isolates of Plasmodium vivax. (1991) (8)
The Santa Lucia strain of Plasmodium falciparum in Aotus monkeys. (2009) (8)
Naturally occurring pupal phenotypes of Anopheles albimanus and their susceptibility to Plasmodium vivax and P. falciparum. (1979) (8)
Studies on infections with two strains of Plasmodium inui from Taiwan in rhesus monkeys and different anopheline mosquitoes. (1998) (8)
Blood parasites of birds at Wateree, South Carolina. (1966) (8)
Preliminary observations on the efficacy of a recombinant multistage Plasmodium falciparum vaccine in Aotus nancymai monkeys. (2005) (8)
Experimental Babesia microti infections in non-splenectomized Macaca mulatta. (1979) (8)
Cellular proliferative responses in squirrel monkeys immunized with recombinant and synthetic Plasmodium vivax circumsporozoite peptides. (1991) (7)
The Uganda I/CDC strain of Plasmodium malariae in Saimiri sciureus boliviensis. (1989) (7)
Comparison of heterologous adult Brugia malayi and homologous Onchocerca volvulus antigen in the enzyme-linked immunosorbent assay (ELISA) for Guatemalan onchocerciasis. (1984) (7)
Serologic studies on onchocerciasis in Guatemala using fixed-tissue sections of adult Onchocerca volvulus. (1980) (7)
The Nigerian I/CDC strain of Plasmodium ovale in chimpanzees. (1996) (7)
Plasmodium inui shortii: studies in old world and new world monkeys. (2009) (7)
Infectivity of a strain of Plasmodium falciparum from Hainan, People's Republic of China, to different anophelines. (1981) (7)
Infection and transmission studies with Plasmodium simiovale in the Macaca mulatta monkey. (1979) (7)
Transmission of St. Louis encephalitis Virus by larval-infected Gulex quinquefasciatus mosquitoes. (1963) (7)
Induction of sporozoite‐specific memory cells in mice immunized with a recombinant Plasmodium vivax circumsporozoite protein (1987) (7)
Plasmodium fragile: detection of a ring-infected erythrocyte surface antigen (RESA). (1988) (7)
An evaluation of malaria fluorescent antibody patterns in several remote island populations of the New Hebrides, Solomons, Western Carolines, and New Guinea. (1976) (7)
The seroepidemiology of malaria in Middle America. IV. Passage of malaria antibodies from mothers to infants. (1977) (7)
Transmission of Different Strains of Plasmodium cynomolgi to Aotus nancymaae Monkeys and Relapse (2009) (7)
Enhancement of in vitro infectivity of simian malaria sporozoites to hepatocytes by centrifugation. (1989) (6)
Development of antibodies to Plasmodium vivax as measured by two different serologic techniques. (1975) (6)
Transmission of Sentliki Forest virus by Anopheles albimanus using membrane feeding techniques. (1963) (6)
FLUORESCENT ANTIBODY REACTIONS AGAINST SIX SPECIES OF SIMIAN MALARIA IN MONKEYS FROM INDIA AND MALAYSIA. (1965) (6)
Monoclonal antibodies to the circumsporozoite protein repeats of a Plasmodium vivax-like human malaria parasite and Plasmodium simiovale. (1994) (6)
Antigenic variations in the plasmodia of lower primates as detected by immuno-fluorescence. (1966) (6)
Observations on the Vietnam Palo Alto Strain of Plasmodium vivax in Two Species of Aotus Monkeys (2005) (6)
Antibodies to the ring-infected erythrocyte surface antigen of Plasmodium falciparum elicited by infection with Plasmodium malariae (1988) (6)
Quantification of Plasmodium malariae infection in mosquito vectors (2004) (6)
Infection and transmission studies with the N-3 strain of Plasmodium fieldi in the Macaca mulatta monkey. (1984) (6)
In‐vitro exoerythrocytic development of Plasmodium cynomolgi bastianellii inhibitory activity of monoclonal antibodies against sporozoites of different P. cynomolgi strains and of P. knowlesi (1989) (6)
STUDIES ON TWO STRAINS OF PLASMODIUM CYNOMOLGI IN NEW WORLD AND OLD WORLD MONKEYS AND MOSQUITOES (2005) (6)
The use of fixed-tissue sections to determine antibodies to Onchocerca volvulus in a fluorescent antibody test. (1979) (6)
Epstein-Barr virus transformation of Saimiri sciureus (squirrel monkey) B cells and generation of a Plasmodium brasilianum-specific monoclonal antibody in P. brasilianum-infected monkeys (1991) (6)
Plasmodium vivax: in vitro development of exoerythrocytic stages in squirrel monkey hepatocytes and inhibition by an anti-P. cynomolgi monoclonal antibody. (1989) (6)
Heparin therapy in simian Plasmodium knowlesi malaria. (1972) (6)
SHIV antigen immunization alters patterns of immune responses to SHIV/malaria coinfection and protects against life-threatening SHIV-related malaria. (2013) (6)
Experimental infection of Anopheles gambiae s.s., Anopheles freeborni and Anopheles stephensi with Plasmodium malariae and Plasmodium brasilianum. (1993) (6)
Infectivity of Plasmodium brasilianum for six species of Anopheles. (1969) (5)
Renal pathology in owl monkeys in Plasmodium falciparum vaccine trials. (1990) (5)
Comparative infectiviry of Plasmodium falciparum (Colombia strain) to Anopheles quadrimaculatus Say and Anopheles albimanus (Wied.). (1962) (5)
Studies on the transmission of simian malaria. 3. Infection and transmission of Plasmodium coatneyi with Anopheles freeborni and A. balabacensis balabacensis mosquitoes. (1967) (5)
Response to treatment in man of multi-drug resistant Plasmodium falciparum from Panama. (1974) (5)
Studies on the transmission of simian malaria. V. Infection and transmission of the B strain of Plasmodium cynomolgi. (1972) (5)
Immunofluorescent staining of exoerythrocytic schizonts of simian plasmodia in fixed tissue. (1973) (5)
Infectivity of Plasmodium simium to Aotus trivirgatus monkeys and different anophelines. (1979) (5)
Infection of Anopheles freeborni mosquitoes on New World monkeys infected with the Uganda I/CDC strain of Plasmodium malariae. (1997) (5)
Renal pathology in owl monkeys vaccinated with Plasmodium falciparum asexual blood-stage synthetic peptide antigens. (1992) (5)
Enzyme-linked immunosorbent assay (ELISA) for serodiagnosis of Guatemalan onchocerciasis: comparison with the indirect fluorescent antibody (IFA) test. (1983) (5)
Studies on the Cambodian I strain of Plasmodium falciparum in Aotus monkeys. (1982) (5)
Observations on the Sporozoite Transmission of Plasmodium vivax to Monkeys (2008) (5)
Immunologic characterization of Plasmodium vivax antigens using Plasmodium cynomolgi liver stage-primed immune sera. (1994) (5)
Adaptation of Plasmodium vivax to growth in owl monkeys (Aotus nancymai). (2005) (5)
Testing of Plasmodium vivax CS proteins in Saimiri monkeys. (1990) (5)
The use of a membrane feeding technique to determine infection and transmission thresholds of Semliki Forest virus in Anopheles quadrimaculatus and Anopheles albimanus. (1964) (4)
Adaptation of a multi-drug resistant strain of Plasmodium falciparum from Peru to Aotus lemurinus griseimembra, A. nancymaae, and A. vociferans monkeys. (2007) (4)
Origin of the St. Elizabeth strain of Plasmodium vivax. (2013) (4)
Some observations on the transmission of Plasmodium inui. (1968) (4)
Studies on the transmission of Semliki Forest virus by anopheline mosquitoes. (1963) (4)
Sequence of a 27-kilodalton gamete antigen of Plasmodium reichenowi and comparison with Pfg27 of Plasmodium falciparum. (1993) (4)
Transmission of the RO Strain of Plasmodium cynomolgi by A. stephensi, A, quadrimaculatus and A. labranchiae atroparvus. (1965) (4)
A monoclonal antibody directed against the sporozoite stage of Plasmodium vivax binds to liver parenchymal cells. (1992) (4)
Letter: Malarial relapse mechanism. (1973) (4)
Transmission of Plasmodium fieldi by Anopheles maculatus, A. stephensi, and A. balabacensis balabacensis. (1968) (4)
The in vitro cultivation of Plasmodium gonderi. (1983) (4)
Infection and transmission studies with Plasmodium gonderi in the Macaca mulatta monkey. (1980) (4)
Fluorescent-antibody studies on simian malaria. II. Development of antibodies to Plasmodium cynomolgi. (1967) (4)
Fluorescent antibody studies on simian malaria. I. Development of antibodies to Plasmodium knowlesi. (1967) (4)
Letter: The antimalarial activity of RC-12 against gametocytes and sporogony of Plasmodium cynomolgi. (1973) (3)
Mosquito infection studies with Aotus monkeys and humans infected with the Chesson strain of Plasmodiun vivax. (2012) (3)
The influence of splenectomy on infections of Plasmodium fieldi in Macaca mulatta monkeys. (1973) (3)
Development of Plasmodium vivax in Saguinus mystax and S. fuscicolis monkeys. (1982) (3)
Changes in Hematologic Values During Infection of New World Monkeys With Plasmodium falciparum and P. vivax. (1998) (3)
Plasmodium fragile: inhibition of cultures by serum from rhesus monkeys immunized with homologous parasites. (1984) (3)
Observations on the relapse activity of Plasmodium simiovale in the rhesus monkey. (1974) (3)
A historical review of the F-1 strain of Anopheles freeborni as a host and vector for studies of malaria. (1999) (3)
Infection of mosquitoes with Plasmodium falciparum by feeding on humans and on Aotus monkeys. (2009) (3)
Development of Plasmodium vivax in chemosterilized anopheline mosquitoes. (1974) (3)
RIO META STRAIN OF PLASMODIUM VIVAX IN NEW WORLD MONKEYS AND ANOPHELINE MOSQUITOES (2004) (3)
Studies of Sindbis virus in Anopheles albimanus and Aedes aegypti. (1966) (3)
Induction of antigen‐specific CD8+ cytolytic T cells by the exogenous bacterial antigen streptolysin O in rhesus monkeys (1991) (3)
An outbreak of Plasmodium inui malaria in a colony of diabetic rhesus monkeys. (1985) (3)
Transmission of Plasmodium vivax from Vietnam by four different anophelines. (1980) (3)
In vitro maturation of the exoerythrocytic stage of Plasmodium knowlesi observed under phase contrast microscopy. (1990) (3)
Potential of the Panama strain of Plasmodium vivax for the testing of malarial vaccines in Aotus nancymai monkeys. (2002) (3)
Parasitized erythrocyte membrane antigens of Plasmodium brasilianum: relationships with the ring-infected erythrocyte surface antigen of Plasmodium falciparum. (1995) (3)
Renal pathology in Saimiri monkeys during a vaccine trial using the recombinant circumsporozoite protein of Plasmodium vivax. (1991) (3)
Infection of mosquitoes with primate malaria (1997) (2)
Studies on the transmission of Semliki Forest virus by Anopheles freeborni, A. stephensi, A. labranchiae atroparvus and A. sundaicus. (1965) (2)
Plasmodium cynomolgi: immunization of a rhesus monkey with exoerythrocytic stages cultured in autologous hepatocytes. (1991) (2)
Monoclonal antibodies to the circumsporozoite protein repeats of a Plasmodium vivax-like human malaria parasite and Plasmodium simiovale (1994) (2)
The exoerythrocytic stages of Plasmodium fragile in Macaca mulatta monkeys. (1977) (2)
The sporogonic cycle of Plasmodium jefferyi. (1969) (2)
Infection and transmission studies with eastern encephalitis virus and Anopheles albimanus and A. quadrimaculatus. (1965) (2)
Studies of Tensaw virus in Anopheles quadrimaculatus, A. albimanus and A. maculatus. (1967) (2)
Detection of anti-Plasmodium falciparum antibodies directed against a repetitive peptide of the gametocyte antigen Pfs2400 in malaria patients in Brazil. (1995) (2)
Studies on the exoerythrocytic stages of simian malaria. 8. Plasmodium knowlesi. (1973) (2)
Fifty years of American parasitology: some fulgent personalities in arthropodology. (1976) (2)
Trans-stadial passage of St. Louis encephalitis virus in Aedes aegypti mosquitoes. (1962) (2)
Infection and Transmission Thresholds' of Eastern Encephalitis Virus to Aedes aegypti as deter mined by a Membrane Feeding Technique. (1965) (2)
ASSESSMENT OF A SYNTHETIC DNA PROBE FOR (1987) (2)
Studies on the exoerythrocytic stages of simian malaria. IX. Plasmodium simium. (1974) (1)
Observations on the Uganda I Strain of Plasmodium malariae and Plasmodium brasilianum in Aotus and Saimiri Monkeys and Anopheles Mosquitoes (2010) (1)
Antigenic diversity in the circumsporozoite protein of human malaria parasites. (1994) (1)
Plasmodium hylobati in the rhesus monkey. (1974) (1)
Interview with the expert: William E. Collins, Ph.D. Interviewed by Vicki Glaser. (2009) (1)
FLUORESCENT ANTIBODY STUDIES IN EXPERIMENTAL MALARIAS. I. STUDIES ON PLASMODIUM GALLINACEUM AND PLASMODIUM BERGHEI (1966) (1)
Plasmodium knowlesi: A Malaria Parasite of Monkeys (2012) (1)
Studies on the laboratory transmission of Group A arboviruses by Anopheline mosquitoes. (1965) (1)
The effect of oral contraceptives in malaria infections in rhesus monkey. (1984) (1)
Diagnosis of Onchocerca volvulus infection in Guatemalan children. (1983) (1)
Studies on the comparative susceptibility of Anopheles freeborni Aitken, A. quadrimaculatits Say, A. labranchiae atroparvus Thiel and A. sundaicus Rodenwaldt to Plasmodium gonderi with a report of transmission by A, freeborni. (1964) (1)
MONKEYS, CHIMPANZEES, AND ANOPHELINE MOSQUITOES (2001) (1)
Malaria endemic sera identify B cell epitopes within non repeat regions of the circumsporozoite protein of Plasmodium falciparum (1991) (0)
FLUORESCENT ANTIBODY STUDIES IN EXPERIMENTAL MALARIAS. III. LIMITATIONS OF THE FLUORESCENT ANTIBODY TECHNIQUE (1966) (0)
FLUORESCENT ANTIBODY STUDIES IN EXPERIMENTAL MALARIAS. II. SIMIAN-HUMAN MALARIA ANTIBODY RELATIONSHIP (1966) (0)
COMPARISON OF HETEROLOGOUS ADULT BRUGIA MALA YI AND HOMOLOGOUS ONCHOCERCA VOL VULUS ANTIGEN IN THE (1984) (0)
Malaria vaccine. (1996) (0)
Malaria vaccine (1996) (0)
ANOPHELES ALBITARSIS MOSQUITOES FROM COLOMBIA (1985) (0)
Seroepidemiology in malaria. (1973) (0)
Plasmodium fieldi: observations on the Hackeri and ABI strains in Macaca mulatta monkeys and mosquitoes. (2009) (0)
Anticorpos dirigidos contra um peptideo repetitivo do antigeno pfs 2400 de gametocitos em pacientes com parasitemia patente por plasmodium falciparum (1995) (0)
EXPERIMENTAL INFECTION OF ANOPHELES FARAUTI WITH DIFFERENT (2002) (0)
Transmission of Eastern Equine Encephalitis Virus by Aedes aegypti infected by Larval Exposure and Membrane Feeding. (1966) (0)
Some observations on the transmission of simian malaria. (1969) (0)
Experimental models in pathology and immunology (Round table 11 - Summary) (1992) (0)
Estimation of the Endohelminth Parasite Species Richness in Freshwater Fishes From La Mintzita Reservoir , Michoacán , Mexico (2014) (0)
TABLE I. Thickness, number of cell layers, and mucus cells in the epidermis of Atlantic salmon parr from the river Batnfordselva (infected with (1997) (0)
Circumsporozoite Proteins of Human Malaria Para 11 Patent Number : 45 ) Date of Patent : 4 , 466 , 917 Aug . 21 , 1984 sites Plasmodium Falciparum and Plasmodium Vivax (2017) (0)
Corals of the St. Louis Limestone in the area of Calhoun County, Illinois and St. Louis County, Missouri (1973) (0)
An apparent inhibition phenomenon in Anopheline mosquitoes infected with Sindbis virus. (1968) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With William Earl Collins?

William Earl Collins is affiliated with the following schools:

William Earl Collins's Academic­Influence.com Rankings

Why Is William Earl Collins Influential?

William Earl Collins's Published Works

Published Works

What Schools Are Affiliated With William Earl Collins?

William Earl Collins's AcademicInfluence.com Rankings